Jiangsu Aidea Pharmaceutical Group Co., Ltd.

6 clinical trials · Sponsor

Record	Firm	Date
Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection (NCT07729839)	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	2026-05-31
Bioequivalence Study of ADC118 Tablets in Healthy Chinese Volunteers Under Fasting Conditions (NCT07753902)	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	2026-04-10
Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (NCT07711223)	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	2025-11-07
Efficacy and Safety of the ACC017-Based Antiretroviral Regimen in Treatment-Experienced Adults With HIV-1 Harboring Non-Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations (NCT07711210)	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	2025-03-21
Phase Ib/IIa Clinical Study of ACC017 Tablets (NCT06719310)	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	2024-08-28
Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants (NCT06278389)	Jiangsu Aidea Pharmaceutical Group Co., Ltd.	2024-01-24

Every clearance here is in the API, with alerts when new ones post.